Getein Biotech Inc (603387) — Cash Flow Quality Index
Getein Biotech Inc (603387) has a Cash Flow Quality Index of 1.95x as of September 2025. Operating cash flow of CN¥100.90 Million exceeds net income of CN¥51.74 Million, indicating high earnings quality where cash backs reported profits. Also explore 603387 asset base for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Getein Biotech Inc Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Getein Biotech Inc across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 603387 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Getein Biotech Inc (2012–2025)
Year-by-year earnings quality comparison for Getein Biotech Inc. For live market cap and the full company financial profile, see 603387 market cap overview.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.78x | CN¥392.59 Million | CN¥220.66 Million | ▼ -3.3% |
| 2024 | 1.84x | CN¥423.00 Million | CN¥229.88 Million | ▲ +56.9% |
| 2023 | 1.17x | CN¥333.22 Million | CN¥284.08 Million | ▲ +22.4% |
| 2022 | 0.96x | CN¥482.96 Million | CN¥503.94 Million | ▼ -8.7% |
| 2021 | 1.05x | CN¥432.36 Million | CN¥412.01 Million | ▲ +86.9% |
| 2020 | 0.56x | CN¥185.47 Million | CN¥330.31 Million | ▼ -13.0% |
| 2019 | 0.65x | CN¥225.73 Million | CN¥349.95 Million | ▼ -13.6% |
| 2018 | 0.75x | CN¥187.10 Million | CN¥250.64 Million | ▼ -24.6% |
| 2017 | 0.99x | CN¥191.91 Million | CN¥193.78 Million | ▼ -12.1% |
| 2016 | 1.13x | CN¥155.91 Million | CN¥138.32 Million | ▼ -3.0% |
| 2015 | 1.16x | CN¥121.73 Million | CN¥104.79 Million | ▼ -12.1% |
| 2014 | 1.32x | CN¥98.53 Million | CN¥74.56 Million | ▲ +45.2% |
| 2013 | 0.91x | CN¥59.72 Million | CN¥65.63 Million | ▼ -16.0% |
| 2012 | 1.08x | CN¥23.80 Million | CN¥21.96 Million | — |